风险因子 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "风险因子" in Chinese language version.

refsWebsite
Global rank Chinese rank
2nd place
23rd place
4th place
5th place
1st place
1st place
9,524th place
325th place
4,367th place
148th place
5th place
12th place
54th place
88th place

doi.org

  • Wald, N J; Hackshaw, A K; Frost, C D. When can a risk factor be used as a worthwhile screening test?. BMJ. 1999, 319 (7224): 1562–1565. ISSN 0959-8138. doi:10.1136/bmj.319.7224.1562. 
  • Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. July 2004, 101 (1): 51–7. PMID 15221988. doi:10.1002/cncr.20312. 
  • Allen NE, Beral V, Casabonne D, et al. Moderate alcohol intake and cancer incidence in women. Journal of the National Cancer Institute. March 2009, 101 (5): 296–305. PMID 19244173. doi:10.1093/jnci/djn514. 
  • Heiss, G.; Wallace, R.; Anderson, G. L.; Aragaki, A.; Beresford, S. A. A.; Brzyski, R.; Chlebowski, R. T.; Gass, M.; Lacroix, A. Health Risks and Benefits 3 Years After Stopping Randomized Treatment with Estrogen and Progestin. JAMA: The Journal of the American Medical Association. 2008, 299 (9): 1036–45. PMID 18319414. doi:10.1001/jama.299.9.1036. 

forbes.com

naer.edu.tw

terms.naer.edu.tw

nih.gov

ncbi.nlm.nih.gov

  • Margolese, Richard G, Bernard Fisher, Gabriel N Hortobagyi, and William D Bloomer. 118. Bast RC, Kufe DW, Pollock RE, et al (编). Cancer Medicine e.5. Hamilton, Ontario: B.C. Decker. 2000 [27 January 2011]. ISBN 1-55009-113-1. (原始内容存档于2020-01-11). 页面存档备份,存于互联网档案馆
  • Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. July 2004, 101 (1): 51–7. PMID 15221988. doi:10.1002/cncr.20312. 
  • Allen NE, Beral V, Casabonne D, et al. Moderate alcohol intake and cancer incidence in women. Journal of the National Cancer Institute. March 2009, 101 (5): 296–305. PMID 19244173. doi:10.1093/jnci/djn514. 
  • Heiss, G.; Wallace, R.; Anderson, G. L.; Aragaki, A.; Beresford, S. A. A.; Brzyski, R.; Chlebowski, R. T.; Gass, M.; Lacroix, A. Health Risks and Benefits 3 Years After Stopping Randomized Treatment with Estrogen and Progestin. JAMA: The Journal of the American Medical Association. 2008, 299 (9): 1036–45. PMID 18319414. doi:10.1001/jama.299.9.1036. 

termonline.cn

web.archive.org

worldcat.org